Skip to main content

Research Repository

Advanced Search

The prognostic significance of ALDH1A1 expression in early invasive breast cancer

Althobiti, Maryam; El Ansari, Rokaya; Aleskandarany, Mohammed; Joseph, Chitra; Toss, Michael S.; Green, Andrew R.; Rakha, Emad A.

The prognostic significance of ALDH1A1 expression in early invasive breast cancer Thumbnail


Authors

Maryam Althobiti

Rokaya El Ansari

Mohammed Aleskandarany

EMAD RAKHA Emad.Rakha@nottingham.ac.uk
Professor of Breast Cancer Pathology



Abstract

Aims: Aldehyde dehydrogenase family 1 member A1 (ALDH1A1)is reportedly a key ALDH isozyme linked to the cancer stem cells (CSC) of many solid tumours, where it is involved in self-renewal, differentiation and self-protection. In this study, the prognostic significance of ALDH1A1 expression in early invasive breast cancer (BC) and its role as a BC stem cell (BCSC) were evaluated.

Methods: ALDH1A1 expression was assessed, using immunohistochemistry and tissue microarrays, in a large well- characterised BC cohort. ALDH1A1 mRNA expression was also assessed at the transcriptomic levels, utilising data from the Molecular Taxonomy of Breast Cancer International Consortium. The associations of ALDH1A1 with clinicopathological parameters, other stem cell markers and patient outcomes were determined.

Results: ALDH1A1 was expressed in 71% of BC cases, at both the protein and mRNA levels. High ALDH1A1 expression was associated with poor prognostic features, including high grade, poor Nottingham Prognostic Index (NPI), lymph node metastasis and highly proliferative ER+ (luminal B) and triple negative (TNBC) subtypes. ALDH1A1 expression was positively correlated with the expression of CD44, CD24, TWIST, SOX9, EPCAM and CD133. The high immunoexpression of ALDH1A1 was significantly associated with poor BC-specific survival [less than] 0.001), and specifically in the luminal B and TNBC subtypes (P=0.042 and P=0.003, respectively). The immunoexpression of ALDH1A1 was an independent predictor of poor prognosis (P=0.015).

Conclusions: ALDH1A1, as assessed using IHC, seems to act as a BCSC marker associated not only with other BCSC markers but also with poor prognostic characteristics and poor outcomes, particularly in the luminal B and TNBC subtypes.

Citation

Althobiti, M., El Ansari, R., Aleskandarany, M., Joseph, C., Toss, M. S., Green, A. R., & Rakha, E. A. (2020). The prognostic significance of ALDH1A1 expression in early invasive breast cancer. Histopathology, 77(3), 437-448. https://doi.org/10.1111/his.14129

Journal Article Type Article
Acceptance Date Mar 10, 2020
Online Publication Date May 5, 2020
Publication Date 2020-09
Deposit Date Mar 25, 2020
Publicly Available Date May 6, 2021
Journal Histopathology
Print ISSN 0309-0167
Electronic ISSN 1365-2559
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 77
Issue 3
Pages 437-448
DOI https://doi.org/10.1111/his.14129
Keywords Pathology and Forensic Medicine; Histology; General Medicine
Public URL https://nottingham-repository.worktribe.com/output/4202139
Publisher URL https://onlinelibrary.wiley.com/doi/abs/10.1111/his.14129?af=R